Ledger.Open graph →
SEC Form D · Amendment · filed May 31, 2012

NEURALTUS PHARMACEUTICALS, INC

Offering
$11.1M
Sold
$11.1M
Exemption
—
Industry
Pharmaceuticals
Location
Palo Alto, CA
Type
—

People & firms on this filing (10)

Andrew Gengos · Palo Alto, CAExec · DirectorTerry Gould · Palo Alto, CADirectorJames Woody · Palo Alto, CADirectorJohn Walker · Palo Alto, CADirectorAnnette Bianchi · Palo Alto, CADirectorWilliam C. Mulligan · Cleveland, OHExec · DirectorGreg B. Schuler · St. Louis, MODirectorMark A. Fralich · Coeur d'Alene, IDDirectorErik A. Panke · Coeur d'Alene, IDDirectorTodd S. Cooper · San Rafael, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗